Following the 2017 hurricane season, the Federal Emergency Management Agency (FEMA) conducted an after-action review of the agency’s preparations for, immediate response to, and initial recovery operations for hurricanes Harvey, Irma, and Maria. The resulting report captures insights from a historic hurricane season that will help the agency, the emergency management community, and the nation chart the path into the future.
This report presents a roadmap for implementing biosecurity and biodefense policy to leverage the capabilities of science and technology advances and minimize security risks. The roadmap contains detailed analyses of the overall system of U.S. biosecurity and biodefense policy, methodologies for evaluating successful implementation of policies, and historical case studies, which were used to develop an analytic framework for assessing potential opportunity costs of biosecurity policy requirements.
This guide explains a seven-step process for emergency managers to expand existing engagement practices with faith-based and community organizations as well as strategize how to further implement whole community principles into emergency management activities.
The Office of the Assistant Secretary for Preparedness and Response within the United States Department of Health and Human Services has released the slide deck from a recent Technical Resources, Assistance Center, and Information Exchange (TRACIE) presentation on the tiered Ebola healthcare response system and how to use resources developed to support highly infectious disease readiness and response efforts.
Comprehensive Preparedness Guide (CPG) 201, Third Edition, provides guidance for conducting the three-step process for a THIRA and the three-step process for an SPR. All types of communities can complete the THIRA/SPR as a way to better understand the risks they face and make important decisions on how to prevent, protect against, mitigate, respond to, and recover from the threats and hazards that pose the greatest risks.
The U.S. Food and Drug Administration (FDA) plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. The FDA ensures that medical countermeasures for these threats are safe, effective, and secure. This annual report details the FDA’s medical countermeasure activities for fiscal year (FY) 2017 (1 October 2016–30 September 2017).
This publication discusses the challenges encountered by first responders during regular duty as well as following disasters, sheds more light on the risks and behavioral health consequences (such as post-traumatic stress disorder, stress, and depression) of serving as a first responder, and presents steps that can be taken to reduce these risks either on the individual or institutional level.
The U.S. Food and Drug Administration issued final guidance, “Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax,” which assists in the development of drugs for prophylaxis (prevention) of inhalational anthrax for individuals who may be potentially exposed to or have inhaled aerosolized Bacillus anthracis (B. anthracis) spores, but who have not yet displayed related signs and symptoms.
The 2015-2016 National Report of Medical Countermeasure Readiness provides insights into the ability of the United States to plan and successfully execute a public health response requiring life-saving medical countermeasures. This report identifies key findings and recommended steps to advance the nation’s health security.
The First Responder Network Authority (FirstNet) is a federal agency created by Congress to oversee the building, deployment, and operation of a new nationwide public safety broadband network. Congress may continue its oversight of FirstNet to ensure the network is meeting public safety needs, requirements in the law are met, and the network is deployed as intended. In providing oversight, Congress may consider the issues reported.